Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.875 GBX | +1.80% | +7.92% | -5.95% |
03-26 | Scancell doses first patient in melanoma-focused trials | AN |
03-22 | Seneca Growth Capital announces tepid 2023 results | AN |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-5.95% | 99.51M | |
+18.05% | 47.02B | |
+48.77% | 41.86B | |
+0.48% | 41.76B | |
-4.27% | 28.8B | |
+11.81% | 26.05B | |
-22.03% | 19.15B | |
+4.55% | 12.55B | |
+29.31% | 12.34B | |
-3.91% | 11.82B |
- Stock Market
- Equities
- SCLP Stock
- News Scancell Holdings plc
- Earnings Flash (SCLP.L) SCANCELL HOLDINGS Reports FY23 Revenue GBP5.3M